{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T21:04:20Z","timestamp":1771967060466,"version":"3.50.1"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bone.2021.115933","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T21:00:03Z","timestamp":1616274003000},"page":"115933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications"],"prefix":"10.1016","volume":"147","author":[{"given":"Parish P.","family":"Sedghizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan C.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmat","family":"Sodagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam F.","family":"Junka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Neighbors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Graham G.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank H.","family":"Ebetino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.115933_bb0010","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/jbmr.2928","article-title":"Marion David Francis: 1923-2016","volume":"31","author":"Ebetino","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2021.115933_bb0015","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1749-6632.1965.tb34834.x","article-title":"Solubility behavior of dental enamel and other calcium phosphates","volume":"131","author":"Francis","year":"1965","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bone.2021.115933_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0003-9969(66)90183-X","article-title":"The effectiveness of anticaries agents in rats using an incipient carious lesion method","volume":"11","author":"Francis","year":"1966","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.bone.2021.115933_bb0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/00220345650440040501","article-title":"Methods of evaluating tin and fluoride salts as anticaries agents in animal caries experiments","author":"Francis","year":"1965","journal-title":"J. Dent. Res."},{"issue":"6","key":"10.1016\/j.bone.2021.115933_bb0030","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2105\/AJPH.38.6.828","article-title":"Mass control of dental caries through the use of domestic water supplies containing fluorine","volume":"38","author":"McKay","year":"1948","journal-title":"Am J Public Health Nations Health."},{"key":"10.1016\/j.bone.2021.115933_bb0035","doi-asserted-by":"crossref","first-page":"17030","DOI":"10.1038\/nrdp.2017.30","article-title":"Dental caries","volume":"3","author":"Pitts","year":"2017","journal-title":"Nat Rev Dis Primers."},{"issue":"2","key":"10.1016\/j.bone.2021.115933_bb0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5644\/ama2006-124.85","article-title":"The cariostatic mechanisms of fluoride","volume":"42","author":"Ro\u0161in-Grget","year":"2013","journal-title":"Acta Med Acad."},{"issue":"7","key":"10.1016\/j.bone.2021.115933_bb0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0022034519831604","article-title":"Fluoride mode of action: once there was an observant dentist","volume":"98","author":"Ten Cate","year":"2019","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2021.115933_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF02058658","article-title":"The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphates","volume":"3","author":"Francis","year":"1969","journal-title":"Calcif. Tissue Res."},{"key":"10.1016\/j.bone.2021.115933_bb0055","first-page":"1296","article-title":"Mechanisms of calcification: role of collagen, polyphosphates, and phosphatase","volume":"200","author":"Fleisch","year":"1961","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bone.2021.115933_bb0060","first-page":"671","article-title":"Isolation from urine of pyrophosphate, a calcification inhibitor","volume":"203","author":"Fleisch","year":"1962","journal-title":"Am. J. Phys."},{"issue":"2","key":"10.1016\/j.bone.2021.115933_bb0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3181\/00379727-122-31123","article-title":"Effect of pyrophosphate on dissolution of hydroxyapatite and its possible importance in calcium homeostasis","volume":"122","author":"Fleisch","year":"1966","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"7348","key":"10.1016\/j.bone.2021.115933_bb0070","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0140-6736(64)92014-8","article-title":"Urinary pyrophosphate and Urolithiasis","volume":"2","author":"Russell","year":"1964","journal-title":"Lancet."},{"issue":"5065","key":"10.1016\/j.bone.2021.115933_bb0075","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/212901a0","article-title":"Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis","volume":"212","author":"Fleisch","year":"1966","journal-title":"Nature."},{"issue":"3899","key":"10.1016\/j.bone.2021.115933_bb0080","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.165.3899.1262","article-title":"Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo","volume":"165","author":"Fleisch","year":"1969","journal-title":"Science."},{"issue":"3899","key":"10.1016\/j.bone.2021.115933_bb0085","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.165.3899.1264","article-title":"Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo","volume":"165","author":"Francis","year":"1969","journal-title":"Science."},{"issue":"10","key":"10.1016\/j.bone.2021.115933_bb0090","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41415-020-2346-4","article-title":"Pyrophosphates in toothpaste: a retrospective and reappraisal","volume":"229","author":"Levine","year":"2020","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.bone.2021.115933_bb0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(69)92293-4","article-title":"Diphosphonates in the treatment of myositis ossificans","volume":"2","author":"Bassett","year":"1969","journal-title":"Lancet."},{"key":"10.1016\/j.bone.2021.115933_bb0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00003086-197107000-00021","article-title":"Effect of disodium Ethane-1-Hydroxy-1,1-Diphosphonate on bone formation","volume":"78","author":"King","year":"1971","journal-title":"Clin Orth Rel Res."},{"key":"10.1016\/j.bone.2021.115933_bb0105","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/rheumatology\/33.4.348","article-title":"Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss","volume":"33","author":"Mulder","year":"1994","journal-title":"Br. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.bone.2021.115933_bb0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","article-title":"Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis","volume":"337","author":"Adachi","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2021.115933_bb0115","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/00220345720510021701","article-title":"A review of the physiological and pharmacological effects of pyrophosphate and diphosphonates on bones and teeth","volume":"51","author":"Fleisch","year":"1972","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2021.115933_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0221-8747(81)90044-8","article-title":"Diphosphonates: history and mechanisms of action","volume":"3","author":"Fleisch","year":"1981","journal-title":"Metab Bone Dis Relat Res."},{"key":"10.1016\/j.bone.2021.115933_bb0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1902\/jop.1992.63.10.825","article-title":"Effects of a bisphosphonate on experimental periodontitis in monkeys","volume":"63","author":"Brunsvold","year":"1992","journal-title":"J. Periodontol."},{"key":"10.1016\/j.bone.2021.115933_bb0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000261242","article-title":"Caries-preventive effect of fluoride dentifrices with and without anticalculus agents: a 3-year controlled clinical trial","volume":"24","author":"Koch","year":"1990","journal-title":"Caries Res."},{"key":"10.1016\/j.bone.2021.115933_bb0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12903-019-0955-6","article-title":"Annual alveolar bone loss in older adults taking oral bisphosphonate: a retrospective cohort study","volume":"19","author":"Helmi","year":"2019","journal-title":"BMC Oral Health."},{"issue":"3","key":"10.1016\/j.bone.2021.115933_bb0140","first-page":"70","article-title":"Efficacy of bisphosphonates for the control of alveolar bone loss in periodontitis","volume":"9","author":"Jeffcoat","year":"2007","journal-title":"J Int Acad Periodontol."},{"key":"10.1016\/j.bone.2021.115933_bb0145","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bcp.13147","article-title":"Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease: a systematic review","volume":"83","author":"Akram","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2021.115933_bb0150","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.biomaterials.2003.08.049","article-title":"Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats","volume":"25","author":"Tengvall","year":"2004","journal-title":"Biomaterials."},{"key":"10.1016\/j.bone.2021.115933_bb0155","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/sj.bdj.2017.412","article-title":"Beyond ONJ - a review of the potential uses of bisphosphonates in dentistry","volume":"222","author":"Shah","year":"2017","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.bone.2021.115933_bb0160","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.bone.2012.02.001","article-title":"A bisphosphonate-coating improves the fixation of metal implants in human bone. A randomized trial of dental implants","volume":"50","author":"Abtahi","year":"2012","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.115933_bb0165","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ijom.2016.09.001","article-title":"Randomised trial of bisphosphonate-coated dental implants: radiographic follow-up after five years of loading","volume":"45","author":"Abtahi","year":"2016","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2021.115933_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/cid.12151","article-title":"The topical administration of bisphosphonates in implant surgery: a randomized split-mouth prospective study with a follow-up up to 5 years","volume":"17","author":"Zuffetti","year":"2015","journal-title":"Clin Implant Dent Relat Res."},{"key":"10.1016\/j.bone.2021.115933_bb0175","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ejo\/cjp068","article-title":"Influence of bisphosphonates on orthodontic tooth movement in mice","volume":"31","author":"Fujimura","year":"2009","journal-title":"Eur. J. Orthod."},{"key":"10.1016\/j.bone.2021.115933_bb0180","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ejo\/26.5.469","article-title":"Effects of local administration of clodronate on orthodontic tooth movement and root resorption in rats","volume":"26","author":"Liu","year":"2004","journal-title":"Eur. J. Orthod."},{"key":"10.1016\/j.bone.2021.115933_bb0185","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/iej.13110","article-title":"Chemical, cytotoxic and genotoxic analysis of etidronate in sodium hypochlorite solution","volume":"52","author":"Ballal","year":"2019","journal-title":"Int. Endod. J."},{"key":"10.1016\/j.bone.2021.115933_bb0190","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/01.don.0000158233.59316.fe","article-title":"Chelation in root canal therapy reconsidered","volume":"31","author":"Zehnder","year":"2005","journal-title":"J Endod."},{"key":"10.1016\/j.bone.2021.115933_bb0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/iej.12329","article-title":"Etidronate causes minimal changes in the ability of sodium hypochlorite to dissolve organic matter","volume":"48","author":"Tartari","year":"2005","journal-title":"Int. Endod. J."},{"key":"10.1016\/j.bone.2021.115933_bb0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2019.03.027","article-title":"Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice","volume":"123","author":"Hokugo","year":"2019","journal-title":"Bone."},{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/jcpt.13056","article-title":"Potential risks of rare serious adverse effects related to long-term use of bisphosphonates: an overview of systematic reviews","volume":"45","author":"Lu","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"issue":"10","key":"10.1016\/j.bone.2021.115933_bb0210","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"O\u2019Ryan F; American Association of Oral and Maxillofacial Surgeons. AAOMS position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.bone.2021.115933_bb0220","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0022034515572021","article-title":"Infection and medication-related osteonecrosis of the jaw","volume":"94","author":"Katsarelis","year":"2015","journal-title":"J. Dent. Res."},{"issue":"9","key":"10.1016\/j.bone.2021.115933_bb0225","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.bjoms.2020.06.030","article-title":"Spontaneous oral ulceration with bone sequestration: its relevance in current clinical practice","volume":"58","author":"Lidhar","year":"2020","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"9","key":"10.1016\/j.bone.2021.115933_bb0230","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"22","key":"10.1016\/j.bone.2021.115933_bb0235","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bone.2021.115933_bb0240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.bone.2021.115933_bb0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.2009.0019","article-title":"Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J Am Dent Assoc."},{"issue":"9","key":"10.1016\/j.bone.2021.115933_bb0255","first-page":"973","article-title":"Important drug precaution for dental health professionals with patients being treated for cancer","volume":"122","author":"Hohneker","year":"2005","journal-title":"Tex Dent J."},{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"36","key":"10.1016\/j.bone.2021.115933_bb0265","volume":"136","year":"2005","journal-title":"J Am Dent Assoc."},{"key":"10.1016\/j.bone.2021.115933_bb0270","article-title":"High stakes for Merck in litigation on Fosamax","volume":"2","author":"Singer","year":"2009","journal-title":"New York Times. September"},{"key":"10.1016\/j.bone.2021.115933_bb0275","first-page":"115735","article-title":"Pharmacologic Management of Metastatic Bone Disease","volume":"7","author":"Schwartz","year":"2020","journal-title":"Bone."},{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0280","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11914-010-0008-1","article-title":"The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy","volume":"8","author":"Kumar","year":"2010","journal-title":"Curr Osteoporos Rep."},{"issue":"11","key":"10.1016\/j.bone.2021.115933_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241676","article-title":"Shotgun metagenome sequencing identification of a set of genes encoded by Actinomyces associated with medication-related osteonecrosis of the jaw","volume":"15","author":"Yahara","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2021.115933_bb0290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41413-020-0088-1","article-title":"Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors","volume":"8","author":"Wan","year":"2020","journal-title":"Bone Res."},{"issue":"4","key":"10.1016\/j.bone.2021.115933_bb0295","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.bone.2021.115933_bb0300","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.joms.2014.07.004","article-title":"Bisphosphonate uptake in areas of tooth extraction or periapical disease","volume":"72","author":"Cheong","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.bone.2021.115933_bb0305","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.oooo.2012.08.455","article-title":"Population pharmacokinetic and pharmacodynamic modeling for assessing risk of bisphosphonate-related osteonecrosis of the jaw","volume":"115","author":"Sedghizadeh","year":"2013","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"issue":"4","key":"10.1016\/j.bone.2021.115933_bb0310","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.oooo.2012.06.006","article-title":"Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis","volume":"114","author":"Schaudinn","year":"2012","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169565","article-title":"Bad to the bone: on in vitro and ex vivo microbial biofilm ability to directly destroy colonized bone surfaces without participation of host immunity or Osteoclastogenesis","volume":"12","author":"Junka","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bone.2021.115933_bb0320","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.joms.2014.09.019","article-title":"Microbial biofilms are able to destroy hydroxyapatite in the absence of host immunity in vitro","volume":"73","author":"Junka","year":"2015","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.bone.2021.115933_bb0325","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00774-009-0128-9","article-title":"Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice","volume":"28","author":"Kobayashi","year":"2010","journal-title":"J. Bone Miner. Metab."},{"issue":"4","key":"10.1016\/j.bone.2021.115933_bb0330","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bone.2011.07.020","article-title":"Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells","volume":"49","author":"Cornish","year":"2011","journal-title":"Bone."},{"issue":"5","key":"10.1016\/j.bone.2021.115933_bb0335","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"5","key":"10.1016\/j.bone.2021.115933_bb0340","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.joms.2011.05.002","article-title":"Effects of pamidronate on human alveolar osteoblasts in vitro","volume":"70","author":"Marolt","year":"2012","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"12","key":"10.1016\/j.bone.2021.115933_bb0345","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","article-title":"IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"Suppl3","key":"10.1016\/j.bone.2021.115933_bb0350","article-title":"Clinical pharmacology of alendronate sodium","volume":"3","author":"Gertz","year":"1993","journal-title":"Osteoporos Int."},{"issue":"10","key":"10.1016\/j.bone.2021.115933_bb0355","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1997.12.10.1700","article-title":"Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis","volume":"12","author":"Khan","year":"1997","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0360","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the International Task Force on ONJ","volume":"20","author":"Khan","year":"2017","journal-title":"J Clin Densitom."},{"key":"10.1016\/j.bone.2021.115933_bb0365","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-017-4063-7","article-title":"A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?","volume":"28","author":"Hasegawa","year":"2017","journal-title":"Osteoporos Int."},{"issue":"6","key":"10.1016\/j.bone.2021.115933_bb0370","first-page":"e788","article-title":"The assessment of surgical and non-surgical treatment of stage II medication-related osteonecrosis of the jaw","volume":"22","author":"Eguchi","year":"2017","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0375","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00198-018-4746-8","article-title":"Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study","volume":"30","author":"Hasegawa","year":"2019","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bone.2021.115933_bb0380","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/odi.12966","article-title":"Drug holiday patterns and bisphosphonate-related osteonecrosis of the jaw","volume":"25","author":"Jung","year":"2019","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0385","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00774-019-01035-7","article-title":"Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw","volume":"38","author":"Hayashida","year":"2020","journal-title":"J. Bone Miner. Metab."},{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0390","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5125\/jkaoms.2020.46.1.78","article-title":"The effect of bisphosphonate discontinuation on the incidence of postoperative medication-related osteonecrosis of the jaw after tooth extraction","volume":"46","author":"Kang","year":"2020","journal-title":"J. Korean Assoc. Oral Maxillofac. Surg."},{"issue":"11","key":"10.1016\/j.bone.2021.115933_bb0395","first-page":"842","article-title":"Paul Ehrlich (1854-1915): man with the magic bullet","volume":"51","author":"Tan","year":"2010","journal-title":"Singap. Med. J."},{"key":"10.1016\/j.bone.2021.115933_bb0400","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ejmech.2011.10.049","article-title":"Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials","volume":"47","author":"McPherson","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bone.2021.115933_bb0405","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1021\/jm0105326","article-title":"Osteoadsorptive bisphosphonate derivatives of fluoroquinolone antibacterials","volume":"45","author":"Herczegh","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bone.2021.115933_bb0410","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1021\/jm801007z","article-title":"Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis","volume":"51","author":"Houghton","year":"2008","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bone.2021.115933_bb0415","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1021\/acs.jmedchem.6b01615","article-title":"Design, synthesis, and antimicrobial evaluation of a novel bone-targeting bisphosphonate-ciprofloxacin conjugate for the treatment of osteomyelitis biofilms","volume":"60","author":"Sedghizadeh","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bone.2021.115933_bb0420","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.bmc.2012.01.024","article-title":"Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis","volume":"20","author":"Arns","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bone.2021.115933_bb0425","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bmc.2009.12.041","article-title":"Design, synthesis, and biological evaluation of novel estradiol-bisphosphonate conjugates as bone-specific estrogens","volume":"18","author":"Morioka","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.bone.2021.115933_bb0430","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1021\/acs.bioconjchem.8b00022","article-title":"Bisphosphonate-linked TrkB agonist: cochlea-targeted delivery of a neurotrophic agent as a strategy for the treatment of hearing loss","volume":"29","author":"Kempfle","year":"2018","journal-title":"Bioconjug. Chem."},{"issue":"2","key":"10.1016\/j.bone.2021.115933_bb0435","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jbmr.3889","article-title":"Targeting Bortezomib to bone increases its bone anabolic activity and reduces systemic adverse effects in mice","volume":"35","author":"Wang","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115933_bb0440","doi-asserted-by":"crossref","first-page":"115492","DOI":"10.1016\/j.bone.2020.115492","article-title":"Targeting anti-cancer agents to bone using bisphosphonates","volume":"138","author":"Xing","year":"2020","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.115933_bb0445","article-title":"Bisphosphonates for delivering drugs to bone","author":"Sun","year":"2020","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.bone.2021.115933_bb0450","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1039\/B512310K","article-title":"\u2018Magic bullets\u2019 for bone diseases: progress in rational design of bone-seeking medicinal agents","volume":"36","author":"Zhang","year":"2007","journal-title":"Chem. Soc. Rev."},{"issue":"8","key":"10.1016\/j.bone.2021.115933_bb0455","doi-asserted-by":"crossref","first-page":"978","DOI":"10.14219\/jada.archive.2009.0307","article-title":"Periodontitis: an archetypical biofilm disease","volume":"140","author":"Schaudinn","year":"2009","journal-title":"J Am Dent Assoc."},{"issue":"7","key":"10.1016\/j.bone.2021.115933_bb0460","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/pathogens9070569","article-title":"Microbial etiology and prevention of dental caries: exploiting natural products to inhibit cariogenic biofilms","volume":"9","author":"Chen","year":"2020","journal-title":"Pathogens."},{"issue":"10","key":"10.1016\/j.bone.2021.115933_bb0465","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.14219\/jada.archive.2009.0049","article-title":"Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J Am Dent Assoc."},{"issue":"1","key":"10.1016\/j.bone.2021.115933_bb0470","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/prd.12280","article-title":"Biofilm as a risk factor in implant treatment","volume":"81","author":"Daubert","year":"2019","journal-title":"Periodontol 2000"},{"key":"10.1016\/j.bone.2021.115933_bb0475","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/BCO.0b013e318230efcf","article-title":"Orthopaedic biofilm infections","volume":"22","author":"Stoodley","year":"2011","journal-title":"Curr Orthop Pract."},{"key":"10.1016\/j.bone.2021.115933_bb0480","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/dkt374","article-title":"Oral antibiotic treatment of staphylococcal bone and joint infections in adults","volume":"69","author":"Kim","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bone.2021.115933_bb0485","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.29.3.405","article-title":"Ciprofloxacin concentrations in bone and muscle after oral dosing","volume":"29","author":"Fong","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bone.2021.115933_bb0490","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jbmr.3055","article-title":"Evidence of staphylococcus aureus deformation, proliferation, and migration in canaliculi of live cortical bone in murine models of osteomyelitis","volume":"32","author":"de Mesy Bently","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2021.115933_bb0495","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jbmr.1543","article-title":"Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo","volume":"27","author":"Roelofs","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115933_bb0500","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0029-1214161","article-title":"Systemic antimicrobial therapy in osteomyelitis","volume":"23","author":"Fraimow","year":"2009","journal-title":"Semin. Plast. Surg."},{"key":"10.1016\/j.bone.2021.115933_bb0505","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.arth.2019.03.008","article-title":"Comparative study of antibiotic elution profiles from alternative formulations of Polymethylmethacrylate bone cement","volume":"34","author":"Meeker","year":"2019","journal-title":"J. Arthroplast."},{"issue":"S1","key":"10.1016\/j.bone.2021.115933_bb0510","first-page":"S31","article-title":"A structure\/activity study of nitrogen heterocycle containing bisphosphonates as bone resorption inhibitors","volume":"38","author":"Benedict","year":"1986","journal-title":"Calcif Tissue Inter."},{"key":"10.1016\/j.bone.2021.115933_bb0515","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/jm7015733","article-title":"Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase","volume":"51","author":"Dunford","year":"2008","journal-title":"J Med Chem."},{"key":"10.1016\/j.bone.2021.115933_bb0520","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0040-4039(01)92575-4","article-title":"The facile dealkylation of phosphonic acid dialkyl esters by bromotrimethylsilane","volume":"18","author":"McKenna","year":"1977","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bone.2021.115933_bb0525","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1039\/c39790000739","article-title":"Functional selectivity in phosphonate ester dealkylation with bromotrimethylsilane","volume":"17","author":"McKenna","year":"1979","journal-title":"J. Chem. Soc. Chem. Commun."},{"issue":"3","key":"10.1016\/j.bone.2021.115933_bb0530","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01267-10","article-title":"Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial","volume":"55","author":"Cachovan","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"issue":"6","key":"10.1016\/j.bone.2021.115933_bb0535","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0924-8579(02)00190-5","article-title":"Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections","volume":"20","author":"Milazzo","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"9","key":"10.1016\/j.bone.2021.115933_bb0540","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/AAC.01550-05","article-title":"Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions","volume":"50","author":"Diz Dios","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.bone.2021.115933_bb0545","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.0303-6979.2004.00490.x","article-title":"Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study","volume":"31","author":"Eick","year":"2004","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.bone.2021.115933_bb0550","doi-asserted-by":"crossref","first-page":"100580","DOI":"10.1016\/j.bonr.2020.100580","article-title":"Real-time impedance-based monitoring of the growth and inhibition of osteomyelitis pathogen Staphylococcus aureus biofilms treated with novel bisphosphonate-fluoroquinolone antimicrobial conjugates","volume":"13","author":"Sedghizadeh","year":"2020","journal-title":"Bone Rep."},{"issue":"S1","key":"10.1016\/j.bone.2021.115933_bb0555","article-title":"Design and in vivo testing of novel bisphosphonate-fluoroquinolone conjugates chemisorbed to bone graft material","volume":"34","author":"Sedghizadeh","year":"2019","journal-title":"J Bone Miner Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221000958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221000958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:55:50Z","timestamp":1757613350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221000958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":111,"alternative-id":["S8756328221000958"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.115933","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.115933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115933"}}